Description

Gliclazide Prolonged Release Tablets IP 60 Mg – GLYCRON 60 PR Tablet
composition  – Gliclazide 60 mg prolonged release

Description:
GLYCRON 60 PR contains Gliclazide Prolonged Release Tablets IP 60 mg formulation designed for effective and sustained glycemic control in patients with type 2 diabetes mellitus. It works by stimulating insulin secretion from pancreatic beta cells and improving peripheral insulin utilization. The prolonged release technology ensures consistent drug levels throughout the day, helping in better fasting and postprandial glucose control with reduced risk of sudden fluctuations.

Key Points
Sustained Glycemic Control
Ensures steady and prolonged blood glucose control throughout the day with its prolonged release formulation, helping to avoid wide fluctuations

Effective Fasting and Postprandial Control
Provides comprehensive glycemic management by controlling both fasting and post meal blood glucose levels

Lower Risk of Hypoglycemia
Gradual and controlte-releaseled drug release reduces the chances of sudden drops in blood sugar levels compared to immedia formulations

Enhances Insulin Secretion
Stimulates pancreatic beta cells to increase insulin release and improves overall glycemic regulation

Targeted Specialties
* Diabetology
* General Medicine
* Endocrinology
* Family Physicians

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.